Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Receives $2.44 Average PT from Brokerages
Shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI – Free Report) have been assigned a consensus recommendation of “Hold” from the five analysts that are presently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation. The average twelve-month price objective among brokerages that have issued a report on the stock in […]